Results 1 to 2 of 2
Page 1 of 1
Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B
B M J Publishing Group. The Journal's web site is located at
Bonino, F; Marcellin, P; Lau, GKK; Hadziyannis, S; Jin, R; Piratvisuth, T; Germanidis, G; Yurdaydin, C; Diago, M; Gurel, S; Lai, MY; Brunetto, MR; Farci, P; Popescu, M; McCloud, P2007228
Responses to peginterferon alfa-2a (40KD) (PEGASYS) treatment are durable in Asian Patients with HBeAg-Negative CHB: 12 month Follow-Up Data from a large Randomised Study
Journal of Gastroenterology and Hepatology
Wiley-Blackwell Publishing Asia. The Journal's web site is located at
Marcellin, P; Lau, GKK; Piratvisuth, T; Jin, R; Lu, ZM; Lai, MY; Thongsawat, S; Ramakrishnan, B; Popescu, M200621
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download